Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer - PubMed (original) (raw)
Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer
Weiguang Chen et al. PLoS One. 2012.
Abstract
Recent reports have suggested the involvement of gut microbiota in the progression of colorectal cancer (CRC). We utilized pyrosequencing based analysis of 16S rRNA genes to determine the overall structure of microbiota in patients with colorectal cancer and healthy controls; we investigated microbiota of the intestinal lumen, the cancerous tissue and matched noncancerous normal tissue. Moreover, we investigated the mucosa-adherent microbial composition using rectal swab samples because the structure of the tissue-adherent bacterial community is potentially altered following bowel cleansing. Our findings indicated that the microbial structure of the intestinal lumen and cancerous tissue differed significantly. Phylotypes that enhance energy harvest from diets or perform metabolic exchange with the host were more abundant in the lumen. There were more abundant Firmicutes and less abundant Bacteroidetes and Proteobacteria in lumen. The overall microbial structures of cancerous tissue and noncancerous tissue were similar; however the tumor microbiota exhibited lower diversity. The structures of the intestinal lumen microbiota and mucosa-adherent microbiota were different in CRC patients compared to matched microbiota in healthy individuals. Lactobacillales was enriched in cancerous tissue, whereas Faecalibacterium was reduced. In the mucosa-adherent microbiota, Bifidobacterium, Faecalibacterium, and Blautia were reduced in CRC patients, whereas Fusobacterium, Porphyromonas, Peptostreptococcus, and Mogibacterium were enriched. In the lumen, predominant phylotypes related to metabolic disorders or metabolic exchange with the host, Erysipelotrichaceae, Prevotellaceae, and Coriobacteriaceae were increased in cancer patients. Coupled with previous reports, these results suggest that the intestinal microbiota is associated with CRC risk and that intestinal lumen microflora potentially influence CRC risk via cometabolism or metabolic exchange with the host. However, mucosa-associated microbiota potentially affects CRC risk primarily through direct interaction with the host.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
Figure 1. Relative abundance of bacterial phyla in microbiota of seven groups of samples.
“Others” represents the unclassified bacteria, Chloroflexi, Deferribacteres, Chlorobi, Deinococcus-Thermus, Acidobacteria, Planctomycetes, Lentisphaerae, Spirochaetes, Synergistetes, Tenericutes, Verrucomicrobia and Cyanobacteria. The first eight phyla were not apparent in stool samples, and the first four phyla were not apparent in swab samples.
Figure 2. PCA plots based on unweighted Unifrac metrics.
Each symbol represents a sample. (A) group cat, stp and swp; (B) group cat, pa2t and pa10t; (C) group swp and swc; (D) group stp and stc.
Figure 3. Different structures of intestinal lumen and cancerous tissue microbiota.
(A) Taxonomic representation of statistically and biologically consistent differences between cancerous tissue and intestinal lumen. Differences are represented by the color of the most abundant class (Red indicating cancerous tissue, yellow non-significant and green intestinal lumen). The diameter of each circle’s diameter is proportional to the taxon’s abundance. (B) Histogram of the LDA scores for differentially abundant genera. Cladogram was calculated by LEfSe, a metagenome analysis approach which performs the linear discriminant analysis following the Wilcoxon Mann-Whitney test to assess effect size of each differentially abundant taxon or OTU; the cladogram is displayed according to effect size.
Figure 4. Relative abundance of significantly different genera between CRC patients and healthy controls.
(A) Genera different between swp and swc. (B) Genera differing between stp and stc. The Mann-Whitney test was used to evaluate the importance of comparisons between indicated groups. *P<0.05, **P<0.01.
Similar articles
- Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer.
Zhu Q, Jin Z, Wu W, Gao R, Guo B, Gao Z, Yang Y, Qin H. Zhu Q, et al. PLoS One. 2014 Mar 6;9(6):e90849. doi: 10.1371/journal.pone.0090849. eCollection 2014. PLoS One. 2014. PMID: 24603888 Free PMC article. - Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer.
Gao Z, Guo B, Gao R, Zhu Q, Wu W, Qin H. Gao Z, et al. Mol Med Rep. 2015 Oct;12(4):6119-27. doi: 10.3892/mmr.2015.4124. Epub 2015 Jul 27. Mol Med Rep. 2015. PMID: 26238090 Clinical Trial. - Tumour-associated and non-tumour-associated microbiota in colorectal cancer.
Flemer B, Lynch DB, Brown JM, Jeffery IB, Ryan FJ, Claesson MJ, O'Riordain M, Shanahan F, O'Toole PW. Flemer B, et al. Gut. 2017 Apr;66(4):633-643. doi: 10.1136/gutjnl-2015-309595. Epub 2016 Mar 18. Gut. 2017. PMID: 26992426 Free PMC article. - Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G, Tralongo P, Damiani P, Sinagra E, Di Trapani B, Zeenny MN, Hussein IH, Jurjus A, Leone A. Tomasello G, et al. World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121. World J Gastroenterol. 2014. PMID: 25561781 Free PMC article. Review. - The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?
Azcárate-Peril MA, Sikes M, Bruno-Bárcena JM. Azcárate-Peril MA, et al. Am J Physiol Gastrointest Liver Physiol. 2011 Sep;301(3):G401-24. doi: 10.1152/ajpgi.00110.2011. Epub 2011 Jun 23. Am J Physiol Gastrointest Liver Physiol. 2011. PMID: 21700901 Free PMC article. Review.
Cited by
- Reduced Epithelial Na+/H+ Exchange Drives Gut Microbial Dysbiosis and Promotes Inflammatory Response in T Cell-Mediated Murine Colitis.
Laubitz D, Harrison CA, Midura-Kiela MT, Ramalingam R, Larmonier CB, Chase JH, Caporaso JG, Besselsen DG, Ghishan FK, Kiela PR. Laubitz D, et al. PLoS One. 2016 Apr 6;11(4):e0152044. doi: 10.1371/journal.pone.0152044. eCollection 2016. PLoS One. 2016. PMID: 27050757 Free PMC article. - Current Hypothesis for the Relationship between Dietary Rice Bran Intake, the Intestinal Microbiota and Colorectal Cancer Prevention.
So WK, Law BM, Law PT, Chan CW, Chair SY. So WK, et al. Nutrients. 2016 Sep 15;8(9):569. doi: 10.3390/nu8090569. Nutrients. 2016. PMID: 27649240 Free PMC article. Review. - Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates.
Ling Z, Liu X, Luo Y, Yuan L, Nelson KE, Wang Y, Xiang C, Li L. Ling Z, et al. BMC Genomics. 2013 Jun 10;14:390. doi: 10.1186/1471-2164-14-390. BMC Genomics. 2013. PMID: 23758874 Free PMC article. - Effect of Gluten-Free Diet on Gut Microbiota Composition in Patients with Celiac Disease and Non-Celiac Gluten/Wheat Sensitivity.
Caio G, Lungaro L, Segata N, Guarino M, Zoli G, Volta U, De Giorgio R. Caio G, et al. Nutrients. 2020 Jun 19;12(6):1832. doi: 10.3390/nu12061832. Nutrients. 2020. PMID: 32575561 Free PMC article. Review. - Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment.
Burns MB, Lynch J, Starr TK, Knights D, Blekhman R. Burns MB, et al. Genome Med. 2015 Jun 24;7(1):55. doi: 10.1186/s13073-015-0177-8. eCollection 2015. Genome Med. 2015. PMID: 26170900 Free PMC article.
References
- Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124:837–848. - PubMed
- Rowland IR. The role of the gastrointestinal microbiota in colorectal cancer. Curr Pharm Des. 2009;15:1524–1527. - PubMed
- Candela M, Guidotti M, Fabbri A, Brigidi P, Franceschi C, et al. Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit Rev Microbiol. 2011;37:1–14. - PubMed
- Wei H, Dong L, Wang T, Zhang M, Hua W, et al. Structural shifts of gut microbiota as surrogate endpoints for monitoring host health changes induced by carcinogen exposure. FEMS Microbiol Ecol. 2010;73:577–586. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical